Dendritic cells in tolerance and autoimmune diabetes

Current Opinion in Immunology

Volumn 25, Issue 6, 2013, Pages 670-675

  Guerder, Sylvie ^a,b,c   Joncker, Nathalie ^a,b,c,d   Mahiddine, Karim ^a,b,c   Serre, Laurent ^a,b,c  

^a France   (France)

^b INSERM   (France)

^c CNRS   (France)

^d INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

SERINE PROTEINASE;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTATION; AUTOIMMUNE DIABETES; AUTOIMMUNE DISEASE; DENDRITIC CELL; EFFECTOR CELL; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE DIFFERENTIATION; MEMORY T LYMPHOCYTE; NONHUMAN; PANCREAS ISLET; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; THYMUS;

ANIMALS; ANTIGEN PRESENTATION; DENDRITIC CELLS; DIABETES MELLITUS, TYPE 1; HUMANS; IMMUNE TOLERANCE; SERINE PROTEASES; THYMUS GLAND;

EID: 84889082734     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2013.10.004     Document Type: Review

References (49)

1. Satpathy A.T., Wu X., Albring J.C., Murphy K.M. Re(de)fining the dendritic cell lineage. Nat Immunol 2012, 13:1145-1154.
2. Merad M., Sathe P., Helft J., Miller J., Mortha A. The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu Rev Immunol 2013, 31:563-604.
3. Dresch C., Leverrier Y., Marvel J., Shortman K. Development of antigen crosspresentation capacity in dendritic cells. Trends Immunol 2012, 33:381-388.
4. Reizis B., Bunin A., Ghosh H.S., Lewis K.L., Sisirak V. Plasmacytoid dendritic cells: recent progress and open questions. Annu Rev Immunol 2011, 29:163-183.
5. Sanos S.L., Nowak J., Fallet M., Bajenoff M. Stromal cell networks regulate thymocyte migration and dendritic cell behavior in the thymus. J Immunol 2011, 186:2835-2841.
6. Koble C., Kyewski B. The thymic medulla: a unique microenvironment for intercellular self-antigen transfer. J Exp Med 2009, 206:1505-1513.
7. Gallegos A.M., Bevan M.J. Central tolerance to tissue-specific antigens mediated by direct and indirect antigen presentation. J Exp Med 2004, 200:1039-1049.
8. Aschenbrenner K., D'Cruz L.M., Vollmann E.H., Hinterberger M., Emmerich J., Swee L.K., Rolink A., Klein L. Selection of Foxp3+ regulatory T cells specific for self antigen expressed and presented by Aire+ medullary thymic epithelial cells. Nat Immunol 2007, 8:351-358.
9. Hinterberger M., Aichinger M., da Costa O.P., Voehringer D., Hoffmann R., Klein L. Autonomous role of medullary thymic epithelial cells in central CD4(+) T cell tolerance. Nat Immunol 2010, 11:512-519.
10. Aichinger M., Wu C., Nedjic J., Klein L. Macroautophagy substrates are loaded onto MHC class II of medullary thymic epithelial cells for central tolerance. J Exp Med 2013, 210:287-300.
11. Coquet J.M., Ribot J.C., Babala N., Middendorp S., van der Horst G., Xiao Y., Neve J.F., Fonseca-Pereira D., Jacobs H., Pennington D.J., et al. Epithelial and dendritic cells in the thymic medulla promote CD4+Foxp3+ regulatory T cell development via the CD27-CD70 pathway. J Exp Med 2013, 210:715-728.
12. Cowan J.E., Parnell S.M., Nakamura K., Caamano J.H., Lane P.J., Jenkinson E.J., Jenkinson W.E., Anderson G. The thymic medulla is required for Foxp3+ regulatory but not conventional CD4+ thymocyte development. J Exp Med 2013, 210:675-681.
13. Lei Y., Ripen A.M., Ishimaru N., Ohigashi I., Nagasawa T., Jeker L.T., Bosl M.R., Hollander G.A., Hayashi Y., Malefyt Rde W., et al. Aire-dependent production of XCL1 mediates medullary accumulation of thymic dendritic cells and contributes to regulatory T cell development. J Exp Med 2011, 208:383-394.
14. Luche H., Ardouin L., Teo P., See P., Henri S., Merad M., Ginhoux F., Malissen B. The earliest intrathymic precursors of CD8alpha(+) thymic dendritic cells correspond to myeloid-type double-negative 1c cells. Eur J Immunol 2011, 41:2165-2175.
15. Li J., Park J., Foss D., Goldschneider I. Thymus-homing peripheral dendritic cells constitute two of the three major subsets of dendritic cells in the steady-state thymus. J Exp Med 2009, 206:607-622.
16. Bonasio R., Scimone M.L., Schaerli P., Grabie N., Lichtman A.H., von Andrian U.H. Clonal deletion of thymocytes by circulating dendritic cells homing to the thymus. Nat Immunol 2006, 7:1092-1100.
17. Hadeiba H., Lahl K., Edalati A., Oderup C., Habtezion A., Pachynski R., Nguyen L., Ghodsi A., Adler S., Butcher E.C. Plasmacytoid dendritic cells transport peripheral antigens to the thymus to promote central tolerance. Immunity 2012, 36:438-450.
18. Proietto A.I., van Dommelen S., Zhou P., Rizzitelli A., D'Amico A., Steptoe R.J., Naik S.H., Lahoud M.H., Liu Y., Zheng P., et al. Dendritic cells in the thymus contribute to T-regulatory cell induction. Proc Natl Acad Sci U S A 2008, 105:19869-19874.
19. Cavanagh L.L., Bonasio R., Mazo I.B., Halin C., Cheng G., van der Velden A.W., Cariappa A., Chase C., Russell P., Starnbach M.N., et al. Activation of bone marrow-resident memory T cells by circulating, antigen-bearing dendritic cells. Nat Immunol 2005, 6:1029-1037.
20. Kurts C., Kosaka H., Carbone F.R., Miller J.F., Heath W.R. Class I-restricted crosspresentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells. J Exp Med 1997, 186:239-245.
21. Hsing L.C., Rudensky A.Y. The lysosomal cysteine proteases in MHC class II antigen presentation. Immunol Rev 2005, 207:229-241.
22. Viret C., Leung-Theung-Long S., Serre L., Lamare C., Vignali D.A., Malissen B., Carrier A., Guerder S. Thymus-specific serine protease controls autoreactive CD4 T cell development and autoimmune diabetes in mice. J Clin Invest 2011, 121:1810-1821.
23. Viken M.K., Blomhoff A., Olsson M., Akselsen H.E., Pociot F., Nerup J., Kockum I., Cambon-Thomsen A., Thorsby E., Undlien D.E., et al. Reproducible association with type 1 diabetes in the extended class I region of the major histocompatibility complex. Genes Immun 2009, 10:323-333.
24. Cheunsuk S., Hsu T., Gershwin M.E., Bowlus C.L. Analysis of the IDDM candidate gene Prss16 in NOD and NON mice. Dev Immunol 2002, 9:183-186.
25. Lie B.A., Viken M.K., Akselsen H.E., Flam S.T., Pociot F., Nerup J., Kockum I., Cambon-Thomsen A., Thorsby E., Undlien D.E. Association analysis in type 1 diabetes of the PRSS16 gene encoding a thymus-specific serine protease. Hum Immunol 2007, 68:592-598.
26. Lesage S., Hartley S.B., Akkaraju S., Wilson J., Townsend M., Goodnow C.C. Failure to censor forbidden clones of CD4 T cells in autoimmune diabetes. J Exp Med 2002, 196:1175-1180.
27. Zucchelli S., Holler P., Yamagata T., Roy M., Benoist C., Mathis D. Defective central tolerance induction in NOD mice: genomics and genetics. Immunity 2005, 22:385-396.
28. Liston A., Lesage S., Gray D.H., O'Reilly L.A., Strasser A., Fahrer A.M., Boyd R.L., Wilson J., Baxter A.G., Gallo E.M., et al. Generalized resistance to thymic deletion in the NOD mouse; a polygenic trait characterized by defective induction of Bim. Immunity 2004, 21:817-830.
29. Latek R.R., Suri A., Petzold S.J., Nelson C.A., Kanagawa O., Unanue E.R., Fremont D.H. Structural basis of peptide binding and presentation by the type I diabetes-associated MHC class II molecule of NOD mice. Immunity 2000, 12:699-710.
30. Mohan J.F., Levisetti M.G., Calderon B., Herzog J.W., Petzold S.J., Unanue E.R. Unique autoreactive T cells recognize insulin peptides generated within the islets of Langerhans in autoimmune diabetes. Nat Immunol 2010, 11:350-354.
31. Stadinski B.D., Zhang L., Crawford F., Marrack P., Eisenbarth G.S., Kappler J.W. Diabetogenic T cells recognize insulin bound to IAg7 in an unexpected, weakly binding register. Proc Natl Acad Sci U S A 2010, 107:10978-10980.
32. Mohan J.F., Petzold S.J., Unanue E.R. Register shifting of an insulin peptide-MHC complex allows diabetogenic T cells to escape thymic deletion. J Exp Med 2011, 208:2375-2380.
33. Stadinski B.D., Delong T., Reisdorph N., Reisdorph R., Powell R.L., Armstrong M., Piganelli J.D., Barbour G., Bradley B., Crawford F., et al. Chromogranin A is an autoantigen in type 1 diabetes. Nat Immunol 2010, 11:225-231.
34. Nakayama M., Abiru N., Moriyama H., Babaya N., Liu E., Miao D., Yu L., Wegmann D.R., Hutton J.C., Elliott J.F., et al. Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice. Nature 2005, 435:220-223.
35. Delong T., Baker R.L., He J., Barbour G., Bradley B., Haskins K. Diabetogenic T cell clones recognize an altered peptide of chromogranin A. Diabetes 2012, 61:3239-3246.
36. Calderon B., Suri A., Miller M.J., Unanue E.R. Dendritic cells in islets of Langerhans constitutively present beta cell-derived peptides bound to their class II MHC molecules. Proc Natl Acad Sci U S A 2008, 105:6121-6130.
37. Yin N., Xu J., Ginhoux F., Randolph G.J., Merad M., Ding Y., Bromberg J.S. Functional specialization of islet dendritic cell subsets. J Immunol 2012, 188:4921-4930.
38. Melli K., Friedman R.S., Martin A.E., Finger E.B., Miao G., Szot G.L., Krummel M.F., Tang Q. Amplification of autoimmune response through induction of dendritic cell maturation in inflamed tissues. J Immunol 2009, 182:2590-2600.
39. Welzen-Coppens J.M., van Helden-Meeuwsen C.G., Leenen P.J., Drexhage H.A., Versnel M.A. The kinetics of plasmacytoid dendritic cell accumulation in the pancreas of the NOD mouse during the early phases of insulitis. PLoS ONE 2013, 8:e55071.
40. Diana J., Simoni Y., Furio L., Beaudoin L., Agerberth B., Barrat F., Lehuen A. Crosstalk between neutrophils B-1a cells and plasmacytoid dendritic cells initiates autoimmune diabetes. Nat Med 2013, 19:65-73.
41. Lutz M.B., Kurts C. Induction of peripheral CD4+ T-cell tolerance and CD8+ T-cell cross-tolerance by dendritic cells. Eur J Immunol 2009, 39:2325-2330.
42. Saxena V., Ondr J.K., Magnusen A.F., Munn D.H., Katz J.D. The countervailing actions of myeloid and plasmacytoid dendritic cells control autoimmune diabetes in the nonobese diabetic mouse. J Immunol 2007, 179:5041-5050.
43. Wen L., Ley R.E., Volchkov P.Y., Stranges P.B., Avanesyan L., Stonebraker A.C., Hu C., Wong F.S., Szot G.L., Bluestone J.A., et al. Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 2008, 455:1109-1110.
44. Li Q., Xu B., Michie S.A., Rubins K.H., Schreriber R.D., McDevitt H.O. Interferonalpha initiates type 1 diabetes in nonobese diabetic mice. Proc Natl Acad Sci U S A 2008, 105:12439-12440.
45. Gallucci S., Lolkema M., Matzinger P. Natural adjuvants: endogenous activators of dendritic cells. Nat Med 1999, 5:1249-1250.
46. Simmons D.P., Wearsch P.A., Canaday D.H., Meyerson H.J., Liu Y.C., Wang Y., Boom W.H., Harding C.V. Type I IFN drives a distinctive dendritic cell maturation phenotype that allows continued class II MHC synthesis and antigen processing. J Immunol 2012, 188:3116-3120.
47. Diamond M.S., Kinder M., Matsushita H., Mashayekhi M., Dunn G.P., Archambault J.M., Lee H., Arthur C.D., White J.M., Kalinke U., et al. Type I interferon is selectively required by dendritic cells for immune rejection of tumors. J Exp Med 2011, 208:1989-1990.
48. Crespo M.I., Zacca E.R., Nunez N.G., Ranocchia R.P., Maccioni M., Maletto B.A., Pistoresi-Palencia M.C., Moron G. TLR7 triggering with polyuridylic acid promotes cross-presentation in CD8alpha+ conventional dendritic cells by enhancing antigen preservation and MHC class I antigen. permanence on the dendritic cell surface. J Immunol 2013, 190:948-960.
49. Le Bon A., Etchart N., Rossmann C., Ashton M., Hou S., Gewert D., Borrow P., Tough D.F. Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon. Nat Immunol 2003, 4:1009-1010.